* Alignment Healthcare Inc ALHC.OQ ALHC.O is expected
to show
a rise in quarterly revenue when it reports results on August
3.
* The Orange California-based company is expected to report
a
19.8% increase in revenue to $439.027 million from $366.47
million a year ago, according to the mean estimate from 8
analysts, based on Refinitiv data. The company's guidance on May
4 2023, for the period ended June 30, was for revenue between
$433.00 million and $438.00 million.
* Refinitiv's mean analyst estimate for Alignment
Healthcare Inc
is for a loss of 22 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Alignment
Healthcare Inc is $10, above its last closing price of $5.88.
The company's guidance on May 4 2023 for the period ended June
30 was for Earnings before Interest, Taxes, Depreciation and
Amortization of between 433 million and -10 million (USD).
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2023 -0.26 -0.25 -0.20 Beat 21.4
Dec. 31 2023 -0.30 -0.30 -0.31 Missed -4.3
Sep. 30 2022 -0.24 -0.25 -0.22 Beat 10.5
Jun. 30 2022 -0.26 -0.26 -0.06 Beat 76.7
Mar. -0.25 -0.25 -0.23 Beat 6.5
31 2022
Dec. 31 2021 -0.31 -0.30 -0.27 Beat 9.6
Sep. 30 2021 -0.17 -0.17 -0.26 Missed -51.5
Jun. 30 2021 -0.11 -0.11 -0.25 Missed -127.3
This summary was machine generated August 2 at 02:08 GMT. All
figures in US dollars unless otherwise stated